SH
Sangeetaben Hasmukhlal Thakkar
About Sangeetaben Hasmukhlal Thakkar
Data last updated:
Sangeetaben Hasmukhlal Thakkar is a Director at Rht Pharmaceuticals Private Limited (since 2015), Director at Roussel Laboratories Private Limited (since 2015) and Director at Duphar Lifesciences Private Limited (since 2015), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹7.57 Cr; the largest is Rht Pharmaceuticals Private Limited at ₹7.29 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rht Pharmaceuticals Private Limited U24230GJ2012PTC073003 | Director | 24 Nov 2015 | 2012 | ₹7.29 Cr (FY 2025) | Active |
| Roussel Laboratories Private Limited U24239GJ2008PTC052808 | Director | 24 Nov 2015 | 2008 | ₹26 Lakh (FY 2025) | Active |
| Duphar Lifesciences Private Limited U24230GJ2009PTC056460 | Director | 24 Nov 2015 | 2009 | ₹2.1 Lakh (FY 2022) | Active |
| Duphar Bioscience Private Limited U24239GJ2011PTC066132 | Director | 24 Nov 2015 | 2011 | ₹10,600 (FY 2025) | Active |
Board colleagues of Sangeetaben Hasmukhlal Thakkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Riteshkumar Dineshkumar Thakkar | 03404669 | Rht Pharmaceuticals Private Limited , Roussel Laboratories Private Limited and 2 more | Director |
| Pragneshkumar Harivallabh Patel | 02189478 | Roussel Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangeetaben Hasmukhlal Thakkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangeetaben Hasmukhlal Thakkar
Sangeetaben Hasmukhlal Thakkar currently holds 4 directorships: Rht Pharmaceuticals Private Limited (Director, since 24 Nov 2015, revenue ₹7.29 Cr (FY 2025)); Roussel Laboratories Private Limited (Director, since 24 Nov 2015, revenue ₹26 Lakh (FY 2025)); Duphar Lifesciences Private Limited (Director, since 24 Nov 2015, revenue ₹2.1 Lakh (FY 2022)); Duphar Bioscience Private Limited (Director, since 24 Nov 2015, revenue ₹10,600 (FY 2025)).
Sangeetaben Hasmukhlal Thakkar was first appointed on 24 Nov 2015 as Director at Rht Pharmaceuticals Private Limited.
The 4 current companies of Sangeetaben Hasmukhlal Thakkar that report revenue have a combined latest revenue of ₹7.57 Cr: Rht Pharmaceuticals Private Limited ₹7.29 Cr (FY 2025); Roussel Laboratories Private Limited ₹26 Lakh (FY 2025); Duphar Lifesciences Private Limited ₹2.1 Lakh (FY 2022); Duphar Bioscience Private Limited ₹10,600 (FY 2025).
The current boards of Sangeetaben Hasmukhlal Thakkar's companies include Riteshkumar Dineshkumar Thakkar (Rht Pharmaceuticals Private Limited), Pragneshkumar Harivallabh Patel (Roussel Laboratories Private Limited).